12/11
11:11 am
nams
Rating for NAMS
Medium
Report
Rating for NAMS
12/11
11:11 am
nams
Rating for NAMS
Medium
Report
Rating for NAMS
12/5
08:01 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Medium
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
12/5
05:18 am
nams
Rating for NAMS
Medium
Report
Rating for NAMS
12/5
05:18 am
nams
Rating for NAMS
Medium
Report
Rating for NAMS
11/21
08:05 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
11/21
04:30 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/21
04:30 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/11
05:54 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/11
05:54 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/7
08:36 am
nams
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
Medium
Report
NewAmsterdam Pharma (NASDAQ: NAMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $36.00 price target on the stock.
11/7
05:07 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/7
05:07 am
nams
Rating for NAMS
Low
Report
Rating for NAMS